Article
Genetic variation in PTX3 and plasma levels associated with hepatocellular carcinoma in patients with HCV.
Journal of viral hepatitis - 1 Feb 2016
Carmo R F, Aroucha D, Vasconcelos L R S, Pereira L M M B, Moura P, Cavalcanti M S M
Abstract excerpt
Hepatitis C virus (HCV) is the main cause of chronic liver disease, cirrhosis and hepatocellular carcinoma (HCC) worldwide. The risk to develop HCC increases with the severity of liver inflammation and fibrosis. Long pentraxin 3 (PTX3) is a soluble pattern-recognition receptor produced by phagocytes and nonimmune cells at sites of inflammation or injury. The aim of the present study was to determine the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
